Mandom stock rating upgraded at Jefferies amid price hikes

Jefferies upgraded Mandom Corp. (4917:JP) to Buy from Hold, raising the price target to ¥1,600 from ¥1,400, citing increased prices in Japan's men's cosmetics market and expansion in Indonesia. The upgrade reflects an optimistic earnings outlook, with Jefferies using a 6x EV/EBITDA valuation based on the fiscal year ending March 2027; analysts anticipate the first quarter to catalyze stock performance as investors focus on earnings following recent reform measures.

Analysis

Jefferies has upgraded Mandom Corp. (4917:JP) stock to Buy from Hold, increasing the price target to ¥1,600 from ¥1,400, signaling renewed optimism in the company's prospects. This positive revision is primarily driven by successful price hikes within Japan's men's cosmetics market and Mandom's strategic expansion of its e-commerce and convenience store channels in Indonesia, which is anticipated to bolster its business model. Jefferies analysts project that the upcoming first-quarter results could serve as a significant catalyst for Mandom's stock performance. The revised ¥1,600 price target stems from upwardly revised earnings outlooks and is predicated on a 6x EV/EBITDA multiple applied to the fiscal year ending March 2027, a forward shift from the previous March 2026 basis; this valuation also corresponds to an 18x price-to-earnings ratio and a 1.0x price-to-book ratio. Following recent reform measures undertaken by the company, investor attention is expected to center on Mandom's evolving earnings trajectory.

Key Decisions for Investors

• Investors should consider the upgraded Buy rating and increased price target as a positive signal for Mandom Corp., supported by specific growth drivers such as price increases in Japan and channel expansion in Indonesia.
• The upcoming first-quarter earnings release should be closely monitored as a potential near-term catalyst for the stock, with particular attention on the realization of benefits from recent strategic initiatives.
• It is advisable to assess Mandom's ability to achieve the earnings growth implied by the forward-looking valuation extended to fiscal year 2027, especially in the context of recent company reforms and market dynamics.